Multidrug resistance Escherichia coli have one of most common resistance in the world. A total of 50 blood samples from Mansoura University Hospitals were collected, isolated, and identified E. coli, by molecular and chemical characterization using the Vitek AST automated technique. The results demonstrated antibiotic sensitivity results showed resistance against ciprofloxacin and moxifloxacin 100%. Ampicillin 100% Ampicillin/Sulbactam (91.93%), Aztreonam (96.93), Cefazolin (72.45%), Ceftazidime (100%), Ceftriaxone (94.68%), Cefepime (96%), Ciprofloxacin (100%), Gentamicn (73%), Moxifloxacin (100%), Nitrofurantoin 83.33%, Piperacillin/Tazobactam (100%), Tobramycin (97.53%), Trimethoprim/Sulfamethoxazoleol (70%), Ticarcillin (100%), Ticarcillin/Cavulanic acid (100%). Laboratory cultures of some fluoroquinolone groups, such as ciprofloxacin, levofloxacin, ofloxacin and norfloxacin, were also found to be resistant to E. coli bacteria. Two strains of Escherichia coli were used, and the antibacterial activity of varying concentrations (25, 50, 75, and 100) of aqueous garlic extract and peppermint was tested against the two strains. The findings revealed that although mint had no effect at all, garlic had a complete effect in all concentrations.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.